NO171147C - Fremgangsmaate for fremstilling av en vaksine mot hepatittb - Google Patents

Fremgangsmaate for fremstilling av en vaksine mot hepatittb

Info

Publication number: NO171147C
Authority: NO; Norway
Prior art keywords: vaccine; hepatitis; zonal; subjected; procedure
Prior art date: 1986-12-10

Application number

NO875142A

Other languages

English (en)

Norwegian (no)

Other versions

NO875142D0 (no

NO875142L (no

NO171147B (no

Inventor

Philippe Jean Adamowicz

Marie Noelle Mevelec

Marc Girard

Original Assignee

Pasteur Vaccins

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-12-10

Filing date

1987-12-09

Publication date

1993-02-03

1987-12-09 Application filed by Pasteur Vaccins filed Critical Pasteur Vaccins

1987-12-09 Publication of NO875142D0 publication Critical patent/NO875142D0/no

1988-06-13 Publication of NO875142L publication Critical patent/NO875142L/no

1992-10-26 Publication of NO171147B publication Critical patent/NO171147B/no

1993-02-03 Publication of NO171147C publication Critical patent/NO171147C/no

Links

SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 title 1
229940124736 hepatitis-B vaccine Drugs 0.000 title 1
238000005119 centrifugation Methods 0.000 abstract 2
241000700721 Hepatitis B virus Species 0.000 abstract 1
150000001450 anions Chemical class 0.000 abstract 1
239000000427 antigen Substances 0.000 abstract 1
102000036639 antigens Human genes 0.000 abstract 1
108091007433 antigens Proteins 0.000 abstract 1
210000004978 chinese hamster ovary cell Anatomy 0.000 abstract 1
238000004587 chromatography analysis Methods 0.000 abstract 1
239000012228 culture supernatant Substances 0.000 abstract 1
238000001914 filtration Methods 0.000 abstract 1
238000005188 flotation Methods 0.000 abstract 1
230000005847 immunogenicity Effects 0.000 abstract 1
230000001939 inductive effect Effects 0.000 abstract 1
239000002245 particle Substances 0.000 abstract 1
239000013612 plasmid Substances 0.000 abstract 1
239000002244 precipitate Substances 0.000 abstract 1
238000001556 precipitation Methods 0.000 abstract 1
230000001954 sterilising effect Effects 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Wood Science & Technology (AREA)
General Health & Medical Sciences (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Virology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Gastroenterology & Hepatology (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Chemistry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

NO875142A 1986-12-10 1987-12-09 Fremgangsmaate for fremstilling av en vaksine mot hepatittb NO171147C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR8617265A FR2608052B1 (fr)	1986-12-10	1986-12-10	Procede de preparation d'un vaccin contre l'hepatite b et vaccin obtenu

Publications (4)

Publication Number	Publication Date
NO875142D0 NO875142D0 (no)	1987-12-09
NO875142L NO875142L (no)	1988-06-13
NO171147B NO171147B (no)	1992-10-26
NO171147C true NO171147C (no)	1993-02-03

Family

ID=9341743

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO875142A NO171147C (no)	1986-12-10	1987-12-09	Fremgangsmaate for fremstilling av en vaksine mot hepatittb

Country Status (11)

Country	Link
EP (1)	EP0273811B1 (de)
JP (1)	JPS63215639A (de)
KR (1)	KR880007732A (de)
AT (1)	ATE109353T1 (de)
CA (1)	CA1306689C (de)
DE (1)	DE3750330T2 (de)
DK (1)	DK645687A (de)
FR (1)	FR2608052B1 (de)
IL (1)	IL84729A (de)
NO (1)	NO171147C (de)
PT (1)	PT86321B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1073604A (zh) *	1991-12-01	1993-06-30	高真南	制备高免疫原性乙型肝炎疫苗的方法
WO1993012815A1 (fr) *	1991-12-27	1993-07-08	Gensci Limited	Procede d'obtention d'un antigene de surface recombine de l'hepatite b, antigene et vaccin a base de celui-ci

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1356413A (en) *	1971-09-09	1974-06-12	Pfizer Ltd	Method of obtaining purified australia antigen from blood serum
US4088748A (en) *	1976-11-02	1978-05-09	Merck & Co., Inc.	Hepatitis B surface antigen
US4162192A (en) *	1978-09-28	1979-07-24	Juridical Foundation	Method for purification of HBs antigen
FR2560890B1 (fr) *	1984-03-07	1987-10-16	Grp Genie Genetique	Composition utile pour la fabrication de vaccins contenant des particules portant l'antigene de surface du virus de l'hepatite b et le recepteur de l'albumine serique humaine polymerisee, cellules animales capables de produire de telles particules et procede pour leur obtention
US4624918A (en) *	1984-07-09	1986-11-25	Genentech, Inc.	Purification process for hepatitis surface antigen and product thereof
US4683294A (en) *	1985-04-03	1987-07-28	Smith Kline Rit, S.A.	Process for the extraction and purification of proteins from culture media producing them

1986
- 1986-12-10 FR FR8617265A patent/FR2608052B1/fr not_active Expired - Lifetime
1987
- 1987-12-03 EP EP87402743A patent/EP0273811B1/de not_active Expired - Lifetime
- 1987-12-03 AT AT87402743T patent/ATE109353T1/de not_active IP Right Cessation
- 1987-12-03 DE DE3750330T patent/DE3750330T2/de not_active Expired - Lifetime
- 1987-12-07 IL IL84729A patent/IL84729A/xx not_active IP Right Cessation
- 1987-12-09 CA CA000553878A patent/CA1306689C/en not_active Expired - Lifetime
- 1987-12-09 PT PT86321A patent/PT86321B/pt not_active IP Right Cessation
- 1987-12-09 NO NO875142A patent/NO171147C/no unknown
- 1987-12-09 DK DK645687A patent/DK645687A/da not_active Application Discontinuation
- 1987-12-10 JP JP62313100A patent/JPS63215639A/ja active Pending
- 1987-12-10 KR KR870014091A patent/KR880007732A/ko not_active Withdrawn

Also Published As

Publication number	Publication date
IL84729A0 (en)	1988-05-31
EP0273811A3 (en)	1988-08-03
CA1306689C (en)	1992-08-25
DE3750330T2 (de)	1994-11-17
NO875142D0 (no)	1987-12-09
EP0273811B1 (de)	1994-08-03
DK645687A (da)	1988-06-11
EP0273811A2 (de)	1988-07-06
JPS63215639A (ja)	1988-09-08
PT86321B (pt)	1990-11-07
DE3750330D1 (de)	1994-09-08
DK645687D0 (da)	1987-12-09
NO875142L (no)	1988-06-13
IL84729A (en)	1993-02-21
FR2608052A1 (fr)	1988-06-17
KR880007732A (ko)	1988-08-29
ATE109353T1 (de)	1994-08-15
NO171147B (no)	1992-10-26
FR2608052B1 (fr)	1990-04-13
PT86321A (fr)	1988-01-01

Similar Documents

Publication	Publication Date	Title
DE3280186D1 (de)	1990-07-05	Synthese von menschlichen viralen antigenen mit hilfe von hefe.
EP0584348A4 (en)	1996-05-29	Genetic vaccine for immunodeficiency viruses
MA21911A1 (fr)	1991-04-01	Procede pour produire une grande proteine de surface modifiee du virus de l'hepatite b .
ATE59409T1 (de)	1991-01-15	Herstellung von oberflaechen-hepatitis-b-antigen in hefe.
FI102616B1 (fi)	1999-01-15	Menetelmä rokotteen valmistamiseksi ihmisen parainfluenssa-viruksen tyyppiä 3 varten ja menetelmässä käytettävä ilmentämisjärjestelmä
NO167359C (no)	1991-10-30	Fremgangsmaate for fremstilling av en vaksine mot infeksjon av hepatitis b virus.
PL279426A1 (en)	1990-01-22	Method of intensifying generation of antigenic hbv particles containing essentially s and pre s2 proteins
AU5572786A (en)	1986-10-16	Expression of immunologically reactive aids viral protein
AU2865084A (en)	1984-11-19	Virus antigen, preparation process thereof and its utilisation in diagnostic and therapy (vaccine)
NO171147C (no)	1993-02-03	Fremgangsmaate for fremstilling av en vaksine mot hepatittb
ATE73349T1 (de)	1992-03-15	Hepatitisoberflaechenantigenpartikelvakzin.
EP0198299A3 (de)	1989-03-22	Verfahren zur Herstellung von Hepatitis-B-Oberflächenantigen enthaltenden Partikeln in neuer Form, die hoch immunogen sind
AU4817885A (en)	1987-04-09	Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom
FR2696748B1 (fr)	1994-12-30	Procédé de préparation d'antigènes et de vaccins de l'hépatite A (HAV).
EP0480525A3 (en)	1992-09-30	Method for obtaining recombinant surface antigen of hepatitis b virus (hep b) of higher immunogenic capacity and use thereof in a vaccine preparation
EP0205625A1 (de)	1986-12-30	Hepatitis-b-virusimpfstoff und dessen herstellung
Gerin et al.	1984	Recombinant DNA and synthetic peptide approaches to HBV vaccine development: Immunogenicity and protective efficacy in chimpanzees.
Michel et al.	1984	Synthesis and secretion of hepatitis-B surface antigen particles in transfected animal cells.
PT72045B (en)	1982-01-26	Process for preparing vaccines for swine protection
ATE53235T1 (de)	1990-06-15	Synthese von menschlichen viralen antigenen mit hilfe von hefe.
Leboulleux et al.	1993	Loss of anti-HBc antibodies after HBV infection in immunized Senegalese children
KR910001033A (ko)	1991-01-30	유전공학적으로 변형된 동물세포에서 생산된 B형 간염 표면항원(HBsAg)의 정제방법
WANG et al.	1983	Experimental study of immune responses in mice induced by nucleic acid vaccine of gag gene of Chinese HIV-1 strains
JPH0762033B2 (ja)	1995-07-05	Ｂ型肝炎ワクチン
BR9705324C1 (pt)	2001-07-31	Método para produção de hbsag purificado para preparação de vacina e vacina recombinante contra a hepatite do tipo b